Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1

Journal of Neurochemistry

Volumn 113, Issue 2, 2010, Pages 454-464

  Roth, Jerome A ^a   Singleton, Steven ^a   Feng, Jian ^a   Garrick, Michael ^a   Paradkar, Prasad N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Divalent metal transporter 1; Iron; Manganese; Parkin; Proteasomal pathway; SH SY5Y cells

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DIVALENT METAL TRANSPORTER 1B; MANGANESE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PARKIN; PROTEASOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ENZYME DEGRADATION; EXON; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IRON TRANSPORT; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

ADULT; ANIMALS; B-LYMPHOCYTES; CATION TRANSPORT PROTEINS; CELL DEATH; CELLS, CULTURED; CHLORIDES; CYSTEINE PROTEINASE INHIBITORS; EXONS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; LEUPEPTINS; MALE; MANGANESE; MANGANESE COMPOUNDS; MICE; MICE, KNOCKOUT; MUTATION; NEUROBLASTOMA; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 77949729459     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06607.x     Document Type: Article

References (54)

1. Andrews N. C. (2008) Forging a field: the golden age of iron biology. Blood 112, 219 230.
2. Basu S., Mohan M. L., Luo X., Kundu B., Kong Q. Singh N. (2007) Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion eplication and disease pathogenesis. Mol. Biol. Cell 18, 3302 3312.
3. Brass S. D., Chen N. K., Mulkern R. V. Bakshi R. (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 17, 31 40.
4. De Domenico I., Vaughn M. B., Li L., Bagley D., Musci G., Ward D. M. Kaplan J. (2006) Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 25, 5396 5404.
5. Dev K. K., van der Putten H., Sommer B. Rovelli G. (2003) Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology 45, 1 13.
6. Dobson A. W., Erikson K. M. Aschner M. (2004) Manganese neurotoxicity. Ann. NY Acad. Sci. 1012, 115 128.
7. Dogu O., Johnson J., Hernandez D., Hanson M., Hardy J., Apaydin H., Ozekmekçi S., Sevim S., Gwinn-Hardy K. Singleton A. (2004) A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. Mov. Disord. 19, 812 816.
8. Fleming M. D., Trenor C. C., Su M. A., Foernzler D., Beier D. R., Dietrich W. F. Andrews N. C. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet. 16, 383 386.
9. Fleming M. D., Romano M. A., Su M. A., Garrick L. M., Garrick M. D. Andrews N. C. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl Acad. Sci. USA 95, 1148 1153.
10. Foot N. J., Dalton H. E., Shearwin-Whyatt L. M., Dorstyn L., Tan S. S., Yang B. Kumar S. (2008) Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood 112, 4268 4275.
11. Garrick M. D., Dolan K. G., Horbinski C. et al. (2003) DMT1: a mammalian transporter for multiple metals. Biometals 16, 41 54.
12. Garrick M. D., Kuo H. C., Vargas F., Singleton S., Zhao L., Smith J. J., Paradkar P., Roth J. A. Garrick L. M. (2006a) Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. Biochem. J. 398, 539 546.
13. Garrick M. D., Singleton S. T., Vargas F. et al. (2006b) DMT1: which metals does it transport? Biol. Res. 39, 79 85.
14. Gerlach M., Ben-Shachar D., Riederer P. Youdim M. B. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793 807.
15. Gruenheid S., Cellier M., Vidal S. Gros P. (1995) Identification and characterization of a second mouse Nramp gene. Genomics 25, 514 525.
16. Gunshin H., Mackenzie B., Berger U. V., Gunshin Y., Romero M. F., Boron W. F., Nussberger S., Gollan J. L. Hediger M. A. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482 488.
17. Guo B., Phillips J. D., Yu Y. Leibold E. A. (1995) Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270, 21645 21651.
18. Haile D. J. (1999) Regulation of genes of iron metabolism by the iron-response proteins. Am. J. Med. Sci. 318, 230 240.
19. Heeney M. M. Andrews N. C. (2004) Iron homeostasis and inherited iron overload disorders: an overview. Hematol. Oncol. Clin. North Am. 18, 1379 1403.
20. Higashi Y., Asanuma M., Miyazaki I., Hattori N., Mizuno Y. Ogawa N. (2004) Parkin attenuates manganese-induced dopaminergic cell death. J. Neurochem. 89, 1490 1497.
21. Hilker R., Klein C., Ghaemi M. et al. (2001) Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann. Neurol. 49, 367 376.
22. Hirsch E. C. Faucheux B. A. (1998) Iron metabolism and Parkinson's disease. Mov. Disord. 13 (Suppl 1 39 45.
23. Hubert N. Hentze M. W. (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl Acad. Sci. USA 99, 12345 12350.
24. Jiang H., Ren Y., Zhao J. Feng J. (2004) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum. Mol. Genet. 13, 1745 1754.
25. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605 608.
26. Kotamraju S., Tampo Y., Keszler A., Chitambar C. R., Joseph J., Haas A. L. Kalyanaraman B. (2003) Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: role of ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 100, 10653 10658.
27. Lee P. L., Gelbart T., West C., Halloran C. Beutler E. (1998) The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Dis. 24, 199 215.
28. Lim K. L., Chew K. C., Tan J. M. et al. (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002 2009.
29. Lis A., Barone T. A., Paradkar P. N., Plunkett R. J. Roth J. A. (2004) Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Mol. Brain Res. 122, 6270.
30. Mackenzie B., Takanaga H., Hubert N., Rolfs A. Hediger M. A. (2007) Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 403, 59 69.
31. Oliveira S. A., Scott W. K., Martin E. R., Nance M. A., Watts R. L., Hubble J. P., Koller W. C., Pahwa R., Stern M. B. Hiner B. C. (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann. Neurol. 53, 624 629.
32. Paradkar P. N. Roth J. A. (2006a) Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. Biochem. J. 394, 173 183.
33. Paradkar P. N. Roth J. A. (2006b) Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-κB. J. Neurochem. 96, 1768 1777.
34. Paradkar P. N. Roth J. A. (2007) Expression of the 1B isoforms of divalent metal transporter (DMT1) is regulated by interaction of NF-Y with a CCAAT-box element near the transcription start site. J. Cell. Physiol. 211, 183 188.
35. Perez F. A. Palmiter R. D. (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl Acad. Sci. USA 102, 2174 2179.
36. Periquet M., Latouche M., Lohmann E., Rawal N., De Michele G., Ricard S., Teive H., Fraix V., Vidailhet M. Nicholl D. (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 126, 1271 1278.
37. Roth J. A. (2006) Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biol. Res. 39, 45 57.
38. Roth J. A. Garrick M. D. (2003) Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 66, 1 13.
39. Roth J. A., Feng L., Dolan K. G., Lis A. Garrick M. D. (2002) Effect of the iron chelator desferrioxamine on manganese-induced toxicity of rat pheochromocytoma (PC12) cells. J. Neurosci. Res. 68, 76 83.
40. Salazar J., Mena N., Hunot S. et al. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 18578 18583.
41. Scheiber-Mojdehkar B., Sturm B., Plank L., Kryzer I. Goldenberg H. (2003) Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells. Eur. J. Biochem. 270, 3731 3738.
42. Schümann K., Moret R., Künzle H. Kühn L. C. (1999) Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa: possible implications for the regulation of iron absorption. Eur. J. Biochem. 260, 362 372.
43. Stankiewicz J., Panter S. S., Neema M., Arora A., Batt C. E. Bakshi R. (2007) Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4, 371 386.
44. Su M. A., Trenor III. C. C., Fleming J. C., Fleming M. D. Andrews N. C. (1998) The G185R mutation disrupts function of the iron transporter Nramp2. Blood 92, 2157 2163.
45. Tabuchi M., Tanaka N., Nishida-Kitayama J., Ohno H. Kishi F. (2002) Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol. Biol. Cell 13, 4371 4387.
46. Takanashi M., Mochizuki H., Yokomizo K., Hattori N., Mori H., Yamamura Y. Mizuno Y. (2001) Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP). Parkinsonism Relat. Disord. 7, 311 314.
47. Thomas M. Jankovic J. (2004) Neurodegenerative disease and iron storage in the brain. J. Curr. Opin. Neurol. 17, 437 442.
48. Touret N., Furuya W., Forbes J., Gros P. Grinstein S. (2003) Dynamic traffic through the recycling compartment couples the metal transporter Nramp2 (DMT1) with the transferrin receptor. J. Biol. Chem. 278, 25548 25557.
49. Touret N., Martin-Orozco N., Paroutis P., Furuya W., Lam-Yuk-Tseung S., Forbes J., Gros P. Grinstein S. (2004) Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia. Blood 104, 1526 1533.
50. Wang X., Garrick M. D., Yang F., Dailey L. A., Piantadosi C. A. Ghio A. J. (2005) TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L24 L33.
51. Wang J., Fillebeen C., Chen G., Biederbick A., Lill R. Pantopoulos K. (2007) Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 27, 2423 2430.
52. Yamanaka K., Ishikawa H., Megumi Y., Tokunaga F., Kanie M., Rouault T. A., Morishima I., Minato N., Ishimori K. Iwai K. (2003) Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5, 336 340.
53. Yang F., Jiang Q., Zhao J., Ren Y., Sutton M. D. Feng J. (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J. Biol. Chem. 280, 17154 17162.
54. Youdim M. B., Ben-Shachar D., Yehuda S. Riederer P. (1990) The role of iron in the basal ganglion. Adv. Neurol. 53, 155 162.